Created in 2018, the Cancer Research & Analytics (CR&A) portfolio was conceived as a scientific investigative hub with a direct line of sight to the people most closely affected by the disease. Embedded within Cancer Care Â鶹ӳ» in Â鶹ӳ» (AHS) ¨C Canada¡¯s first and largest province-wide, fully-integrated health system ¨C CR&A has unique proximity to clinical practice, raising and answering important patient-focused research questions across the entire cancer continuum.
From discovering more about how the disease starts and progresses, to better prevention and earlier detection, to providing more targeted treatment and stronger support for patients, families and caregivers, CR&A researchers and data experts are exploring impactful, innovative, and sustainable ways to help people in Â鶹ӳ» who face cancer now, and in the years ahead.
CR&A¡¯S Dual & Intertwined Goals
